Chromocell Therapeutics Corp (CHRO) has provided an announcement.
Chromocell Therapeutics Corporation has announced Francis Knuettel II as its new CEO starting March 13, 2024. Knuettel, who has been serving as the interim CEO since July 2023, boasts a track record of significant financial growth in previous roles, including increasing Unrivaled Brands’ revenue tenfold. With experience in raising over $300 million and managing numerous mergers, Knuettel’s extensive financial and leadership background positions him as a strategic choice for steering the company forward.
Find detailed analytics on CHRO stock on TipRanks’ Stock Analysis page.
